Comcapsy 700 mg/30 mg Tablet

Comcapsy 700 mg/30 mg Tablet contains capecitabine 700 mg and cyclophosphamide 30 mg, combining two anticancer medicines. It is mainly used as part of chemotherapy treatment for certain advanced or metastatic cancers, including breast cancer. The tablet is taken orally according to the treatment schedule prescribed by the oncologist.

BUY NOW

Capecitabine is converted in the body to 5-fluorouracil, which interferes with DNA synthesis and inhibits the growth of rapidly dividing cancer cells. Cyclophosphamide damages cancer-cell DNA through an alkylating mechanism, providing a complementary anticancer action. Regular monitoring of blood counts and clinical parameters is important because treatment may cause nausea, diarrhea, hand-foot syndrome, fatigue, and reduced blood-cell counts. The dosage and treatment cycles are individualized by the treating oncologist according to the cancer type, treatment response, and overall clinical condition.

Technical Specification

Specification Details
Active Ingredients Capecitabine + Cyclophosphamide
Strength 700 mg + 30 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 tablets
Manufacturer Intas Pharmaceuticals Ltd

Product Also Known As

Comcapsy 700mg/30mg Tablet, Comcapsy 700 mg/30 mg Tablet, Comcapsy 700/30 Tablet, Capecitabine 700mg + Cyclophosphamide 30mg Tablet, Capecitabine Cyclophosphamide Tablet, Comcapsy 700/30mg Anticancer Tablet